HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunohistochemical characterization of mononuclear cells in delayed hypersensitivity reactions to Paracoccidiodes brasiliensis (paracoccidioidin test).

Abstract
The density and distribution of T cells, T helper cells, macrophages and B cells at the site of skin tests with a cytoplasmic Paracoccidioides brasiliensis antigen (paracoccidioidin) was studied at 24 and 48 h post-challenge in 10 patients with the chronic form of paracoccidioidomycosis and in 5 non-infected individuals. The in situ study was carried out using immunoperoxidase techniques and monoclonal antibodies. The controls showed negative skin test. In the patients, the great majority of the cells in the perivascular foci were T cells (CD43-positive cells) making up 47% and 48.6% of the total number of cells at 24 and 48 h respectively. Most of the T cells showed a T helper phenotype (CD45RO-positive cells). Approximately 25% of the cells were macrophages (CD68-positive cells) and there were very few B lymphocytes (CD20-positive cells). The present data on the microanatomy of paracoccidioidin skin test sites were consistent with a delayed type hypersensitivity pattern. Our results were comparable to those reported on skin tests for other granulomatous chronic diseases.
AuthorsM Marques, M Moscardi-Bacchi, S Marques, M Franco
JournalMycopathologia (Mycopathologia) Vol. 124 Issue 1 Pg. 7-11 (Oct 1993) ISSN: 0301-486X [Print] Netherlands
PMID8159219 (Publication Type: Journal Article)
Chemical References
  • Fungal Proteins
  • paracoccidioidin
Topics
  • Adult
  • Chronic Disease
  • Fungal Proteins (immunology)
  • Humans
  • Hypersensitivity, Delayed (immunology)
  • Immunoenzyme Techniques
  • Immunophenotyping
  • Intradermal Tests
  • Leukocytes, Mononuclear (immunology)
  • Male
  • Paracoccidioides
  • Paracoccidioidomycosis (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: